Riversedge Advisors, LLC Cor Medix Inc. Transaction History

Riversedge Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$4.47 - $5.56 $12,900 - $16,046	-2,886 Reduced 20.24%	11,373 $52,000
Q2 2020 Aug 03, 2020	BUY	$3.08 - $6.56 $8,436 - $17,967	2,739 Added 23.78%	14,259 $90,000
Q4 2019 Feb 13, 2020	BUY	$4.96 - $7.75 $57,139 - $89,280	11,520 New	11,520 $84,000

130

19.8M

414K

467K

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $427M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

Get notified when there are updates to the investment portfolio of Riversedge Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Riversedge Advisors, LLC with notifications on news.